Dapagliflozin Improves Erythropoiesis and Iron Metabolism in Type 2 Diabetic Patients with Renal Anemia

PURPOSE: In this study, we examined the effects of dapagliflozin on changes in hematopoiesis, iron metabolism, and body composition indices in elderly type 2 diabetic patients with renal impairment and investigated the potential of dapagliflozin to treat renal anemia. PATIENTS AND METHODS: The parti...

Descripción completa

Detalles Bibliográficos
Autores principales: Osonoi, Takeshi, Shirabe, Shinichiro, Saito, Miyoko, Hosoya, Mitsuru, Watahiki, Norie, Douguchi, Satako, Ofuchi, Kensuke, Katoh, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290476/
https://www.ncbi.nlm.nih.gov/pubmed/37363130
http://dx.doi.org/10.2147/DMSO.S411504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290476/
https://www.ncbi.nlm.nih.gov/pubmed/37363130
http://dx.doi.org/10.2147/DMSO.S411504

Ejemplares similares